NCT06295861

Prospective Cohort Study of Panvascular Disease

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50,000 (estimated)
• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To construct a comprehensive big data platform for Chinese people with panvascular disease, and establish a Chinese panvascular disease oriented to guide treatment decisions Cohort and imaging, biological database; According to the clinical features, morphological structure, pathological characteristics of panvascularization, vascular age As the core of the evaluation, a standard evaluation system and a risk prediction model of intervention technology suitable for the diagnosis and treatment of patients with panvascular disease in China were established. Into the Further optimize the treatment strategies, protocols and clinical pathways for panvascular disease to improve patient prognosis and promote its application.

Conditions

• ASCVD

Interventions

Type	Name	Description
OTHER	no different intervention between the two cohort.	no different intervention between the two cohort.

Timeline

• Start date: 2024-02-21
• Primary completion: 2028-11-30
• Completion: 2028-12-31
• First posted: 2024-03-06
• Last updated: 2024-03-06

Locations

2 sites across 1 country: China